68
Participants
Start Date
May 10, 2021
Primary Completion Date
May 9, 2025
Study Completion Date
July 30, 2025
Lumason
Lumason will be administered at a dose of 0.03 mL/kg up to a maximum dose of 2.4mL injected into a peripheral intravenous catheter. An abdominal contrast enhanced ultrasound will be performed to look for solid organ injury. The will be given twice during the intervention, for a total maximum dose per subject of 4.8mL.
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Texas Southwestern Medical Center, Dallas
University of Utah, Salt Lake City
Phoenix Children's Hospital, Phoenix
Boston Children's Hospital, Boston
David Mooney
OTHER